brain neoplasms/nutukimas

Nuoroda įrašoma į mainų sritį

Straipsniai Klinikiniai tyrimai Patentai

Pasirinkite rūšiavimo tipą

Puslapis 1 nuo 117 rezultatus

Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Hypothalamic obesity causes unrelenting weight gain for childhood brain tumor survivors. No single therapy has proven effective for treatment. We aimed to evaluate effectiveness of long-term methylphenidate therapy on body mass index (BMI) change in children with hypothalamic

Risk factors for the development of obesity in children surviving brain tumors.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Hypothalamic obesity, a syndrome of intractable weight gain due to hypothalamic damage, is an uncommon but devastating complication for children surviving brain tumors. We undertook a retrospective evaluation of the body mass index (BMI) curves for the St. Jude Children's Research Hospital brain

Obesity and metabolic changes are common in young childhood brain tumor survivors.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

BACKGROUND A population based cross-sectional study was used to examine the prevalence of metabolic syndrome and its components in childhood brain tumor survivors. METHODS Fifty-two survivors were examined at a mean age of 14.4 years (range 3.8-28.7). Lipid and glucose metabolism, thyroid function,

The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Survivors of childhood brain tumours (SCBT) are at risk of type 2 diabetes and cardiovascular diseases. Obesity is a major driver of cardiometabolic diseases in the general population, and interventions that tackle obesity may lower the risk of these chronic diseases. The goal of this systematic

Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

BACKGROUND Childhood obesity has reached epidemic proportions and is impacting children's health globally. In adults, obesity is associated with chronic low-grade inflammation that leads to insulin resistance, which is one of the important mechanisms through which dysregulation of metabolism occurs.

Risk factors for obesity in childhood survivors of suprasellar brain tumours: a retrospective study.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

OBJECTIVE To characterize postdiagnosis changes in body mass index (BMI) among childhood survivors of suprasellar brain tumours, and to determine the risk factors associated with obesity. METHODS We conducted a retrospective analysis of 46 children (16 boys and 30 girls) with median (IQR) age of

Overweight, obesity and adiposity in survivors of childhood brain tumours: a systematic review and meta-analysis.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Survivors of childhood brain tumours (SCBT) have increased cardiometabolic risks, but the determinants of these risks are unclear. This systematic review aims to compare the prevalence of overweight and obesity as well as adiposity measures between SCBT and non-cancer controls. The PubMed, EMBASE,

Metabolic syndrome is a sequela of radiation exposure in hypothalamic obesity among survivors of childhood brain tumors.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Survivors of childhood brain tumors may be at risk for early onset of metabolic syndrome, possibly secondary to surgery and/or radiation exposure. This study examines effects of radiation exposure to hypothalamus-pituitary-adrenal axis (HPA) on metabolic risk among survivors of childhood brain

Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

The objectives of this study were to evaluate outcomes of a comprehensive care clinic (CCC) for children with hypothalamic obesity due to treatment for brain tumors by assessing weight parameters; health-related quality of life (HRQoL); and perception of health status, disease burden, care

Prevalence of obesity, hyperlipemia and insulin resistance in children with suprasellar brain tumors.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Weight gain is a common sequela of suprasellar tumors, referred to as hypothalamic obesity. We undertook an evaluation of obesity and metabolic aberrations among patients treated at our institute. During the 12 mo from Apr. 2005, 23 patients (10 males and 13 females) with remitted suprasellar tumors

Brain tumor necrosis factor-α mediates anxiety-like behavior in a mouse model of severe obesity.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Although the high prevalence of anxiety in obesity increasingly emerges as significant risk factor for related severe health complications, the underlying pathophysiological mechanisms remain poorly understood. Considering that chronic inflammation is a key component of obesity and is well known to

Brain cancer risk: the weight of obesity.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Obesity may protect against benign brain tumors.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Objective: Hypothalamic obesity (HO) in children after treatment for a tumor in the suprasellar region has severe implications. Previous studies have shown various effects of glucagon-like peptide-1 (GLP-1) receptor agonist in acquired

Abnormal weight gain with fatigue and stress in early survivorship after childhood brain tumor diagnosis.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Diagnosis and treatment for individuals with brain tumors during childhood involves sequelae, including abnormal weight gain. This symptom is commonly clustered with fatigue and increased risk for cardiovascular disease. Children's Oncology Group recommendations include annual

Ankstesnis
1
2
3
4
5
6
7
8
Kitas

Prisijunkite prie mūsų
„Facebook“ puslapio

Herbal & Natural Medicine

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

Dirba 55 kalbomis
Žolelių gydymas, paremtas mokslu
Vaistažolių atpažinimas pagal vaizdą
Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
Skaitykite mokslines publikacijas, susijusias su jūsų paieška
Ieškokite vaistinių žolelių pagal jų poveikį
Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais